This chapter:

1. A. Defines:

   1. (1) Mifepristone data;
   2. (2) Health information exchange;
   3. (3) Electronic health network; and
   4. (4) Protected Health Care Commission;

2. B. Lists the:

   1. (1) Mifepristone data, and diagnosis, procedure, and related codes for abortion care that are subject to the restrictions on the disclosure of health care information; and
   2. (2) Diagnosis, procedure, and related codes for gender-affirming treatment that are subject to the restrictions on the disclosure of health care information;
3. C. Describes to whom these restrictions apply; and
4. D. Sets forth the restrictions on data.

Authority: Health-General Article, §4-302.5 Annotated Code of Maryland

Effective date: September 16, 2024 (51:18 Md. R. 809)

Regulation .01B amended effective May 11, 2026 (53:9 Md. R. 413)

Regulation .02B amended effective May 11, 2026 (53:9 Md. R. 413)

Regulation .04B amended effective May 11, 2026 (53:9 Md. R. 413)

Regulation .06 recodified to Regulation .07 effective May 11, 2026 (53:9 Md. R. 413)

Regulation .06 adopted effective May 11, 2026 (53:9 Md. R. 413)